“Of all the strategems, to know when to quit is the best.” – Chinese Proverb. Knowing the right time to make a change at work is a sign of wisdom…

Seven months after Prevail Therapeutics launched, the company has secured $75 million in Series A financing to support the development of gene therapies for Parkinson’s disease. Source: BioSpace

Sanofi SA and Evotec AG have teamed up to form an infectious disease research and development program. Source: BioSpace

Cyteir Therapeutics snagged $29 million and a new chief executive officer as the company pushes forward to develop small-molecule inhibitors in the fight against cancer. Source: BioSpace

This week Pfizer notified the Bay Area-based company of its intent to terminate its five-year-old oncology collaboration. Source: BioSpace

John Reed, who for five years has led Roche’s Pharma Research and Early Development (pRED) research group, is stepping down for personal reasons. Source: BioSpace

U.S. insurer Cigna is acquiring pharmacy benefits manager Express Scripts for approximately $67 billion. Source: BioSpace

JW Therapeutics, a clinical stage biopharma company founded by Juno Therapeutics and WuXi AppTec Group, has closed a Series A financing worth $90 million. Source: BioSpace

Esperion announced that its bempedoic acid for lowering LDL-C cholesterol had positive results in a Phase III clinical trial. Source: BioSpace

Ligand Pharmaceuticals is licensing LGD-6972, a glucagon receptor antagonist (GRA), to Roivant Sciences for $20 million. Source: BioSpace